Literature DB >> 3684235

Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease.

J J Augsburger1, J W Gamel, J A Shields, A M Markoe, L W Brady.   

Abstract

To determine the prognostic value of the regression rate of choroidal melanomas after cobalt-60 plaque radiotherapy, the authors performed a multivariate analysis on 159 patients treated with a cobalt plaque during the interval from 1976 through 1980. Thirty-three of the 159 patients had died as of the survey date; 29 of metastatic melanoma and 4 of other causes. Multivariate Cox proportional hazards modeling identified a two-term regression incorporating maximal basal tumor diameter at treatment and tumor thickness at 12 months posttreatment as the best model (P less than 0.005 for both parameters) for predicting length of tumor-free survival. These results are consistent with the hypothesis that rapid regression of a choroidal melanoma after cobalt-60 plaque radiotherapy is an unfavorable prognostic sign for prolonged metastasis-free survival.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3684235     DOI: 10.1016/s0161-6420(87)33310-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Indirect ophthalmoscope laser treatment as supplement to 125I plaque therapy for choroidal melanoma.

Authors:  J J Augsburger; D Mullen; M Kleineidam
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.

Authors:  Kishan Gupta; Colin A McCannel; Mitchell Kamrava; James Lamb; Robert D Almanzor; Tara A McCannel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-24       Impact factor: 3.117

3.  Gene expression profiling and regression rate of irradiated uveal melanomas.

Authors:  Rajesh C Rao; Mehnaz Khan; Shahed N Badiyan; J William Harbour
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-03       Impact factor: 1.300

4.  Precision of ultrasonic estimates of choroidal melanoma regression.

Authors:  R Rask; P K Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

5.  Uveal Melanoma Regression after Brachytherapy: Relationship with Chromosome 3 Monosomy Status.

Authors:  Sachin M Salvi; Hassan A Aziz; Suhail Dar; Nakul Singh; Brandy Hayden-Loreck; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2016-10-29

6.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Combined iodine-125 plaque irradiation and indirect ophthalmoscope laser therapy of choroidal malignant melanomas: comparison with iodine-125 and cobalt-60 plaque radiotherapy alone.

Authors:  J J Augsburger; M Kleineidam; D Mullen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

8.  Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.

Authors:  I Kaiserman; I Anteby; I Chowers; E Z Blumenthal; I Kliers; J Pe'er
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

9.  Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.

Authors:  Royce W S Chen; J William Harbour
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-12       Impact factor: 3.117

10.  Internal resection of posterior uveal melanomas.

Authors:  P J Kertes; J C Johnson; G A Peyman
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.